The limited efficacy of the BCG vaccine against tuberculosis is partly due to the missing expression of immunogenic proteins. We analyzed whether the addition to BCG of ESAT-6 and HspX, two Mycobacterium tuberculosis (Mtb) antigens, could enhance its capacity to activate human dendritic cells (DCs). BCG showed a weak ability to induce DC maturation, cytokine release, and CD4(+) lymphocytes and ...

CONTEXT The duration of protection from tuberculosis of BCG vaccines is not known. OBJECTIVE To determine the long-term duration of protection of a BCG vaccine that was previously found to be efficacious. DESIGN Retrospective record review using Indian Health Service records, tuberculosis registries, death certificates, and supplemental interviews with trial participants. SETTING AND PART...

Bacillus Calmette-Guérin (BCG), the only approved tuberculosis vaccine, provides only limited protection. Previously, we generated a recombinant derivative (BCG ΔureC::hly), which secretes the pore-forming toxin listeriolysin O (LLO) of Listeria monocytogenes. This vaccine shows superior protection against tuberculosis in preclinical models and is safe in humans. Here we describe two new vaccin...

the purpose of this study was to evaluate the efficacy ofthe bcg vaccine in the first 60 days of life in inducing delayed-type hypersensitivity (dth), and to evaluate the reliability of the mantoux test in comparison with the bcg test for detecting dth. a study was done in 885 healthy, well nourished infants 5 to 7 months old from rural areas of the urumieh province, who received bcg immunizati...

BCG is an immune modulatory that inducing humoral and cellular immune responses during a number of infections including cutaneous leishmaniasis. Killed Leishmania Vaccine (KLV) has been applied for its immunogenicity in hosts. This study was carried out between 2010 and 2011 at the Department of Parasitology, Pasteur Institute of Iran. In the present study, alterations of Nitric Oxide (NO) leve...

Background. Thirty to forty percent of patients with high grade nonmuscle invasive bladder cancer (NMIBC) fail to respond to intravesical therapy with bacillus Calmette-Guerin (BCG). Interferon-α2B plus BCG has been shown to be effective in a subset of patients with NMIBC BCG refractory disease. Here we present a contemporary series on the effectiveness and safety of intravesical BCG plus inter...

Natural bactericidal resistance to Mycobacterium bovis BCG is under the control of a single gene, designated Bcg. Lung granuloma formation in susceptible (Bcgs) and resistant (Bcgr) mice was studied in two sets of Bcg-congenic systems, namely, the BALB/c (Bcgs)-C.D2 (BALB/c.Bcgr) pair and the B10.A (Bcgs)-B10.Ar (Bcgr) pair, by using BCG as well as foreign body granuloma-inducing agents (dextra...

BACKGROUND Randomised trials have shown that early Bacille Calmette-Guérin (BCG) vaccine reduces overall neonatal and infant mortality. However, no study has examined how BCG affects growth. We investigated the effect on infant growth of early BCG vaccine given to low-birth-weight (LBW) infants. METHODS Two-thousand three hundred forty-three LBW infants were randomly allocated 1:1 to "early B...

The anti-tuberculosis Bacille de Calmette et Guérin (BCG) vaccine was developed between 1905 and 1921 at Pasteur Institutes of Lille in France, and was adopted by many countries. BCG strains comprise natural mutants of major virulence factors of Mycobacterium tuberculosis and that BCG sub-strains differ markedly in virulence levels. The tuberculosis became endemic in Korea after the Korean War ...

Abstract Innate immune cells, such as monocytes, can generate a non-specific ‘memory’ response (a.k.a. trained immunity) upon stimulation with an antigen/bacterium (e.g., LPS or BCG), which confers heterologous protection against another infectious agent. However, the association between nature of stimulants and corresponding correlate immunity is not fully understood. Similarly, macrophages “t...